CDTX Competitors & Alternatives
Compare Cidara Therapeutics Inc with similar stocks in the same industry
Biotechnology
CDTX
Main Stock$221.38
Tradestie Score
50
Market Cap
$2.44B
Revenue Growth
-1.0%
Analyst Upside
+0.1%
Top Competitors
219 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
JAZZ
Jazz Pharmaceuticals, Inc.
|
$248.24
|
$8.30B | 72.6 | 31 | Compare |
|
MRUS
Merus N.V. Common Shares
|
$90.00
|
$7.14B | - | 39 | Compare |
|
CYTK
Cytokinetics Inc.
|
$58.53
|
$6.68B | - | 61 | Compare |
|
RYTM
Rhythm Pharmaceuticals, Inc. Common Stock
|
$112.16
|
$6.64B | - | 29 | Compare |
|
ABVX
Abivax SA American Depositary Shares
|
$91.44
|
$6.38B | - | 63 | Compare |
|
LEGN
Legend Biotech Corporation American Depositary Shares
|
$19.54
|
$6.03B | - | 33 | Compare |
|
CRSP
CRISPR Therapeutics AG
|
$45.75
|
$6.02B | - | 48 | Compare |
|
NUVL
Nuvalent, Inc. Class A Common Stock
|
$123.96
|
$5.95B | - | 44 | Compare |
|
AXSM
Axsome Therapeutics, Inc
|
$149.24
|
$5.92B | - | 55 | Compare |
|
TGTX
TG Therapeutics, Inc.
|
$65.76
|
$5.80B | 95.9 | 35 | Compare |
More CDTX Analysis
Data updated: Nov 12, 2026 | Industry: Biotechnology (SIC 2836)
219 stocks in this industry